These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21656721)

  • 1. Long-term global quality of life in patients treated for colorectal liver metastases.
    Wiering B; Oyen WJ; Adang EM; van der Sijp JR; Roumen RM; de Jong KP; Ruers TJ; Krabbe PF
    Br J Surg; 2011 Apr; 98(4):565-71; discussion 571-2. PubMed ID: 21656721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life after surgical treatment of colorectal liver metastases.
    Langenhoff BS; Krabbe PF; Peerenboom L; Wobbes T; Ruers TJ
    Br J Surg; 2006 Aug; 93(8):1007-14. PubMed ID: 16739102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
    Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
    Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent colorectal liver metastases: who benefits from a second hepatic resection?].
    Konopke R; Volk A; Gastmeier J; Ehehalt F; Distler M; Saeger HD; Kersting S
    Zentralbl Chir; 2014 Apr; 139(2):226-34. PubMed ID: 23846538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival.
    Andreou A; Knitter S; Schmelzle M; Kradolfer D; Maurer MH; Auer TA; Fehrenbach U; Lachenmayer A; Banz V; Schöning W; Candinas D; Pratschke J; Beldi G
    Surgery; 2021 May; 169(5):1061-1068. PubMed ID: 33386128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-Related Quality of Life as a Prognostic Factor in Patients After Resection of Hepatic Malignancies.
    Tohme S; Sanin GD; Patel V; Bress K; Ahmed N; Krane A; Tsung A; Steel JL
    J Surg Res; 2020 Jan; 245():257-264. PubMed ID: 31421371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
    Ruers TJ; Joosten JJ; Wiering B; Langenhoff BS; Dekker HM; Wobbes T; Oyen WJ; Krabbe PF; Punt CJ
    Ann Surg Oncol; 2007 Mar; 14(3):1161-9. PubMed ID: 17195903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of predictive factors for recurrence after hepatectomy for colorectal liver metastases.
    Yamada H; Kondo S; Okushiba S; Morikawa T; Katoh H
    World J Surg; 2001 Sep; 25(9):1129-33. PubMed ID: 11571947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after repeat hepatic resection for recurrent colorectal metastases.
    Chiappa A; Zbar AP; Biella F; Staudacher C
    Hepatogastroenterology; 1999; 46(26):1065-70. PubMed ID: 10370668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat hepatic surgery for colorectal cancer metastasis to the liver.
    Pinson CW; Wright JK; Chapman WC; Garrard CL; Blair TK; Sawyers JL
    Ann Surg; 1996 Jun; 223(6):765-73; discussion 773-6. PubMed ID: 8645050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of colorectal liver metastases - workflow].
    Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
    Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment.
    Snoeren N; Voest EE; Bergman AM; Dalesio O; Verheul HM; Tollenaar RA; van der Sijp JR; Schouten SB; Rinkes IH; van Hillegersberg R
    BMC Cancer; 2010 Oct; 10():545. PubMed ID: 20937118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment for colorectal liver metastases involving the paracaval portion of the caudate lobe.
    Yamamoto H; Nagino M; Kamiya J; Hayakawa N; Nimura Y
    Surgery; 2005 Jan; 137(1):26-32. PubMed ID: 15614278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of follow-up after surgical treatment of colorectal liver metastases.
    Langenhoff BS; Krabbe PF; Ruers TJ
    Eur J Surg Oncol; 2009 Feb; 35(2):180-6. PubMed ID: 18691847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeat hepatic resection for colorectal liver metastases.
    Adair RA; Young AL; Cockbain AJ; Malde D; Prasad KR; Lodge JP; Toogood GJ
    Br J Surg; 2012 Sep; 99(9):1278-83. PubMed ID: 22864889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life from a randomized trial of laparoscopic or open liver resection for colorectal liver metastases.
    Fretland ÅA; Dagenborg VJ; Waaler Bjørnelv GM; Aghayan DL; Kazaryan AM; Barkhatov L; Kristiansen R; Fagerland MW; Edwin B; Andersen MH
    Br J Surg; 2019 Sep; 106(10):1372-1380. PubMed ID: 31322735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.